Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
mingjie xie
(66 results)?
Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite.
Pharm Res. 2022 Sep;39(9):2147-2162. doi: 10.1007/s11095-022-03324-9. Epub 2022 Jul 6.
Pharm Res. 2022.
PMID: 35790618
Spontaneous Formation of Fluorescent Carbon Nanoparticles in Glutaraldehyde Solution and Their Fluorescence Mechanism.
Zuo P, Zhang J, Zhou Y, Xie N, Xiao D.
Zuo P, et al. Among authors: xie n.
J Fluoresc. 2021 Mar;31(2):509-516. doi: 10.1007/s10895-020-02678-w. Epub 2021 Jan 15.
J Fluoresc. 2021.
PMID: 33449252
Item in Clipboard
Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers.
Liu L, Li W, Yang L, Guo ZT, Xue H, Xie NJ, Chen XY.
Liu L, et al.
Acta Pharmacol Sin. 2022 Apr;43(4):1082-1090. doi: 10.1038/s41401-021-00710-8. Epub 2021 Jul 15.
Acta Pharmacol Sin. 2022.
PMID: 34267345
Free PMC article.
Item in Clipboard
Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities.
Xie N, Wang H, Qin H, Guo Z, Xue H, Hu J, Chen X.
Xie N, et al.
Pharmaceutics. 2022 Dec 8;14(12):2743. doi: 10.3390/pharmaceutics14122743.
Pharmaceutics. 2022.
PMID: 36559237
Free PMC article.
Item in Clipboard
Drug interaction of ningetinib and gefitinib involving CYP1A1 and efflux transporters in non-small cell lung cancer patients.
Liu L, Wang Q, Xie C, Xi N, Guo Z, Li M, Hou X, Xie N, Sun M, Li J, Chen X.
Liu L, et al. Among authors: xie n.
Br J Clin Pharmacol. 2021 Apr;87(4):2098-2110. doi: 10.1111/bcp.14621. Epub 2020 Nov 15.
Br J Clin Pharmacol. 2021.
PMID: 33098714
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite